bioRxivPathology
Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis
M. Mora, S. Zanotti, S. Gibertini, F. Blasevich, C. Bragato, S. Saredi, C. Introna, P. Bernasconi, L. Maggi, R. Mantegazza
Abstract
We investigated in vitro and in vivo the pro-fibrotic role of exosomes released by muscle-derived fibroblasts of Duchenne muscular dystrophy (DMD) patients, and of miRNAs carried by exosomes. We found that exosomes from DMD fibroblasts, but not from myoblasts, had significantly higher levels of miR-199a-5p, a miRNA up-regulated in fibrotic conditions, compared to control exosomes. In control fibroblasts, exposure to DMD fibroblast-derived exosomes induced a myofibroblastic phenotype with increase in -smooth actin, collagen and fibronectin transcript and protein expression, soluble collagen production and deposition, cell proliferation, and activation of Akt and ERK signalling, while exposure to control exosomes did not. These findings were related to transfer of high levels of miR-199a-5p and to reduction of its target caveolin-1. Finally, injection of DMD fibroblast-derived exosomes into mouse tibialis anterior muscle after cardiotoxin-induced necrosis, produced greater fibrosis than control exosomes.\n\nOur findings indicate that exosomes produced by local fibroblasts in the DMD muscle are able to induce phenotypic conversion of normal fibroblasts to myofibroblasts thereby increasing the fibrotic response; and suggest miR-199a-5p and caveolin-1as potential therapeutic targets.
- organism: mouse
- organism: human
- assay: proteomics
- assay: multiome
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Disease exacerbation by fibroblast inclusion in Duchenne Muscular Dystrophy MYOrganoids reveals limitations of microdystrophin therapeutic efficacy
L. Palmieri, L. Pili, … S. Albini·bioRxiv·Jul 26, 2023
- NOX4 inhibition promotes the remodeling of dystrophic muscle
D. W. Hammers·bioRxiv·Jan 8, 2022
- Urine-derived exosomes from individuals with IPF carry pro-fibrotic cargo.
S. Elliot, P. Catanuto, … M. K. Glassberg·bioRxiv·May 6, 2022
- Targeting fibrosis in the Duchenne Muscular Dystrophy mice model: an uphill battle
M. Theret, M. Low, … F. M. V. Rossi·bioRxiv·Jan 20, 2021
- The microRNA, miR-133b, functions to slow Duchenne muscular dystrophy pathogenesis
T. Taetzsch, D. Shapiro, … G. Valdez·bioRxiv·Mar 19, 2020
- A Novel In Vitro Potency Assay Demonstrating the Anti-Fibrotic Mechanism of Action of CDCs in Deramiocel
Y Li, Justin B. Nice, … Minghao Sun·BiomedicinesPeer-reviewed·Oct 29, 2025